CVS Bay Area Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

CVS Bay Area şirketinin toplam hissedar öz sermayesi ¥4.1B ve toplam borcu ¥5.2B olup, bu da borç-öz sermaye oranını 127.1% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥11.0B ve ¥6.9B dir. CVS Bay Area 'in FAVÖK'ü ¥487.0M faiz karşılama oranı 13.5 dur. Şirketin ¥2.4B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

127.1%

Borç/özkaynak oranı

JP¥5.24b

Borç

Faiz karşılama oranı	13.5x
Nakit	JP¥2.45b
Eşitlik	JP¥4.12b
Toplam yükümlülükler	JP¥6.92b
Toplam varlıklar	JP¥11.04b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

CVS Bay Area's (TSE:2687) Attractive Earnings Are Not All Good News For Shareholders

Oct 22

Earnings Working Against CVS Bay Area Inc.'s (TSE:2687) Share Price

Oct 16

Additional Considerations Required While Assessing CVS Bay Area's (TSE:2687) Strong Earnings

Apr 19

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 2687 'nin kısa vadeli varlıkları ( ¥3.3B ) kısa vadeli yükümlülüklerini ( ¥3.0B ) aşıyor.

Uzun Vadeli Yükümlülükler: 2687 'un kısa vadeli varlıkları ( ¥3.3B ) uzun vadeli yükümlülüklerini ( ¥3.9B ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 2687 'nin net borç/öz sermaye oranı ( 67.7% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: 2687 şirketinin borç/öz sermaye oranı son 5 yılda 58.8% seviyesinden 127.1% seviyesine yükseldi.

Borç Kapsamı: 2687 'nin borcu işletme nakit akışı ( 9.9% ) tarafından iyi bir şekilde karşılanmıyor.

Faiz Kapsamı: 2687 'in borcuna ilişkin faiz ödemeleri EBIT ( 13.5 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.

CVS Bay Area Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 2/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

CVS Bay Area Inc. to Report Q3, 2025 Results on Jan 10, 2025

CVS Bay Area's (TSE:2687) Attractive Earnings Are Not All Good News For Shareholders

Earnings Working Against CVS Bay Area Inc.'s (TSE:2687) Share Price

Second quarter 2025 earnings released: EPS: JP¥133 (vs JP¥20.87 in 2Q 2024)

New major risk - Financial data availability

Upcoming dividend of JP¥10.00 per share

Investor sentiment deteriorates as stock falls 25%

CVS Bay Area Inc. to Report Q2, 2025 Results on Oct 11, 2024

First quarter 2025 earnings released: EPS: JP¥31.60 (vs JP¥27.55 in 1Q 2024)

Full year 2024 earnings released: EPS: JP¥141 (vs JP¥2.63 loss in FY 2023)

Now 20% undervalued after recent price drop

New minor risk - Share price stability

Now 21% undervalued after recent price drop

CVS Bay Area Inc. to Report Q1, 2025 Results on Jul 10, 2024

Additional Considerations Required While Assessing CVS Bay Area's (TSE:2687) Strong Earnings

Investor sentiment deteriorates as stock falls 19%

Now 26% undervalued after recent price drop

CVS Bay Area Inc., Annual General Meeting, May 29, 2024

Full year 2024 earnings released: EPS: JP¥141 (vs JP¥2.63 loss in FY 2023)

Upcoming dividend of JP¥10.00 per share

CVS Bay Area Inc. to Report Fiscal Year 2024 Results on Apr 12, 2024

Third quarter 2024 earnings released: EPS: JP¥31.20 (vs JP¥0.41 loss in 3Q 2023)

Second quarter 2024 earnings released: EPS: JP¥20.87 (vs JP¥12.76 loss in 2Q 2023)

Investor sentiment improves as stock rises 24%

Upcoming dividend of JP¥10.00 per share at 2.2% yield

CVS Bay Area Inc. to Report Q2, 2024 Results on Oct 11, 2023

Investor sentiment improves as stock rises 25%

New major risk - Financial position

First quarter 2024 earnings released: EPS: JP¥27.55 (vs JP¥3.04 loss in 1Q 2023)

Full year 2023 earnings released: JP¥2.63 loss per share (vs JP¥168 loss in FY 2022)

CVS Bay Area Inc. to Report Q1, 2024 Results on Jul 12, 2023

Full year 2023 earnings released: JP¥2.63 loss per share (vs JP¥168 loss in FY 2022)

Upcoming dividend of JP¥8.00 per share at 3.8% yield

Third quarter 2023 earnings released: JP¥0.41 loss per share (vs JP¥11.95 loss in 3Q 2022)

CVS Bay Area Inc. to Report Q3, 2023 Results on Jan 11, 2023

No independent directors

Second quarter 2023 earnings released: JP¥12.76 loss per share (vs JP¥7.90 loss in 2Q 2022)

CVS Bay Area Inc. to Report Q2, 2023 Results on Oct 12, 2022

Upcoming dividend of JP¥8.00 per share

First quarter 2023 earnings released: JP¥3.04 loss per share (vs JP¥38.49 loss in 1Q 2022)

Full year 2022 earnings released: JP¥168 loss per share (vs JP¥235 loss in FY 2021)

CVS Bay Area Inc. to Report Q1, 2023 Results on Jul 13, 2022

No independent directors

CVS Bay Area Inc., Annual General Meeting, May 31, 2022

Full year 2022 earnings released: JP¥168 loss per share (vs JP¥235 loss in FY 2021)

CVS Bay Area Inc. to Report Fiscal Year 2022 Results on Apr 13, 2022

Upcoming dividend of JP¥8.00 per share

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: JP¥7.90 loss per share (vs JP¥15.19 profit in 2Q 2021)

Upcoming dividend of JP¥8.00 per share

First quarter 2022 earnings released: JP¥38.49 loss per share (vs JP¥71.31 loss in 1Q 2021)

Full year 2021 earnings released: JP¥235 loss per share (vs JP¥81.24 loss in FY 2020)

Full year 2021 earnings released: JP¥235 loss per share (vs JP¥81.24 loss in FY 2020)

CVS Bay Area Inc. to Report Fiscal Year 2021 Results on Apr 14, 2021

Third quarter 2021 earnings released: JP¥64.02 loss per share

New 90-day low: JP¥402

CVS Bay Area Inc. to Report Q2, 2021 Results on Oct 14, 2020

CVS Bay Area Inc. to Report Q1, 2021 Results on Jul 30, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin